SCHEMBL27716582

SCHEMBL27716582

Nc1cc(N=S(=O)=O)ccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ GAA P10253 1/20 0.37
▸ HTR3E A5X5Y0 2/20 0.34
▸ HTR3B O95264 2/20 0.34
▸ HTR3A P46098 2/20 0.34
▸ HTR3D Q70Z44 2/20 0.34
▸ HTR3C Q8WXA8 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ SLC9A1 P19634 1/20 0.33
▸ CYP3A4 P08684 3/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11295534 0.77 TSHR (0.50) TSHRTP53CA12CA1CA2
SCHEMBL27716593 0.76 LMNA (0.32) TDP1MAPTLMNAALDH1A1
SCHEMBL27716615 0.76 TDP1 (0.45) TSHRTP53GAAMAPK1TDP1
SCHEMBL10889596 0.76 GAA (0.42) TSHRCA12CA1CA2CA9
SCHEMBL11682158 0.76 TSHR (0.46) TSHRTP53CA12CA2CA9
SCHEMBL27716709 0.73 ALDH1A1 (0.35) GAAALDH1A1
SCHEMBL11684152 0.73 TSHR (0.42) TSHRTP53CA12CA1CA2
SCHEMBL11684625 0.73 SENP3 (0.43) TSHRTP53CA1CA2GAA
SCHEMBL11647217 0.69 MAPT (0.58) TSHRTP53CA12CA1CA2
SCHEMBL11647216 0.69 MAPT (0.58) TSHRTP53CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348203-B Inhibit the composition and method of JAK approach 里格尔药品股份有限公司 2018-09-18 — — CN disclosed
CN-105348203-A Compositions and methods for inhibition of the JAK pathway RIGEL PHARMACEUTICALS INC 2016-02-24 — — CN disclosed
CN-101282945-A Compositions and methods for inhibiting the JAK pathway RIGEL PHARMACEUTICALS INC (US) 2008-10-08 — — CN disclosed
Send feedback